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Objective: The aim of this study was to investigate the relationship of MACC-1 (metastasis-associated in colon
cancer 1) and microRNA (miRNA) hsa-miR-574-5p and the function of hsa-miR-574-5p in colorectal cancer liver
metastasis.
Methods: Liver-metastatic nude mice model was constructed by injecting two human colorectal cancer cell lines
(SW1116 and HCT116) labeled with green fluorescent protein (GFP) through spleen, and liver metastasis incidences
were evaluated. We identified miRNAs that might regulate MACC-1 expression by bioinformatics analysis and further
investigated the relationship of MACC-1 and hsa-miR-574-5p by luciferase reporter assay, quantitative RT-PCR and
western blot. The effect of hsa-miR-574-5p on colony formation, cell invasion and cell spheroid formation was
investigated by antisense transfected HCT116 cells and miRNA mimic transfected SW1116 cells.
Results: The volume of liver metastasis induced by SW1116 cells (25.0 ± 4.4%) was significantly higher than that
induced by HCT116 cells. Bioinformatics analysis showed hsa-miR-574-5p negatively regulated MACC-1 and then
their interaction was demonstrated at mRNA and protein level. The direct relation between them was confirmed by
luciferase reporter assay. And the knockdown of has-miR-574-5p demonstrated increased colony formation, cell
invasion and cell spheroid formation in HCT116 cells, compared to control group (P < 0.05). Reverse results were
obtained in mimic transfected SW1116 cells.
Conclusion: Our work firstly demonstrated that hsa-miR-574-5p negatively regulated MACC-1 expression in
colorectal cancer cells. It was partly elucidated that hsa-miR-574-5p played a suppressive role in colorectal cancer
liver metastasis by negatively directing MACC-1 expression, offering a novel therapeutic approach for colorectal
cancer liver metastasis.
Keywords: Colorectal cancer, MACC-1, miRNA, Liver metastasisIntroduction
Colorectal cancer liver metastasis is a bottleneck world-
wide, which restricts patients from long-term survival.
There are about 500,000 cases of colorectal cancer liver
metastasis every year [1]. Once liver metastasis hap-
pens, the prognosis is often very poor [2]. Until recently,
the incidence of liver metastasis for colorectal cancer
patients is still very high. More than 70% patients with
liver metastasis cannot be surgically resected [2]. Even
after hepatectomy, the 2-year recurrence rate is as high* Correspondence: wangzh1972@126.com
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unless otherwise stated.as 75%, and 5-year overall survival rate is only 26.8%
[3,4]. Although high attention has been paid to the colo-
rectal cancer liver metastasis in clinical practice, the
underlying molecular mechanism is still limited, thus
lacking of effective prevention and intervention. There-
fore, it is imperative to explore the mechanisms and
look for new intervention targets and methods for colo-
rectal cancer liver metastasis in both clinical practice
and basic research.
It is a dynamic process for cancer cells to spread from
the primary tumor to distant organs, and to develop
metastasis. More than one gene are involved in this
continuous and multiple-stage process, involving many. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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extracellular matrix remodeling, angiogenesis, genesis
of lymphatic vessels, and immune system [5]. Recent
study has shown that tumor metastasis is closely re-
lated to cancer cell epithelial-mesenchymal transition
(EMT) and cancer stem cells (CSC) [6]. The high expres-
sion of α, β integrin in colorectal cancer cells facilitates
the integration with portal and hepatic venous epithelial
cells and the homing [7,8]. Metastasis-associated in colon
cancer 1 (MACC-1) is recently discovered as an extremely
important metastasis-related gene to regulate the metasta-
sis of colorectal cancer as well as a variety of other solid
tumors [9]. MACC-1, which is located on chromosome 7
(7p21.1), regulates HGF/c-Met signaling pathway that is
involved in three major aspects of cancer metastasis-EMT,
homing and CSC [10-13]. MACC-1 could be targeted by
miR-143 to inhibit cell invasion and migration in colorec-
tal cancer [14]. It has been reported that down-regulation
of miR-1 and increase of MACC1 contributed to overex-
pression of Met in human colon cancer [15].
Lots of evidences have shown that microRNAs (miRNAs),
the important regulators of functional genes, are involved
in oncogenesis and tumor development [16,17]. Existing
data also support that miRNAs expression are abnormal
in the colorectal cancer cells. For example, low expression
of miR-145 is related to the colorectal cancer [18], yet also
reported in lung cancer [19] as CRC and lung cancer share
epidermal growth factor receptor (EGFR) property [18,19].
The inflammatory cytokines such as IL (interleukin)-6,
IL-8, IL-10, IL-12a and NOS2a (nitric oxide synthase),
are positively correlated to miR-21 expression in colorectal
cancer adjacent tissues, both of which are independent
contributors to the poor prognosis of colorectal cancer
[20]. It has been reported that hsa-miR-574-5p decreased
CBR1 (carbonyl resuctase 1) gene expression and activity
[21] and negatively regulated Qki6/7 to impact β-catenin/
Wnt signalling and the development of colorectal cancer
[22]. However, it is not completely clear which miRNAs
are the regulators for MACC-1 which is the key candidate
gene for colorectal cancer liver metastasis. Therefore, it is
necessary to investigate the effects and molecular mecha-
nisms of MACC-1 and its upstream regulatory miRNAs
to modulate colorectal cancer liver metastasis.
In the present work, we identified the miRNAs profiles
that might regulate the MACC-1 expression by bioinfor-
matics analysis and investigated the relation between
miRNA and MACC-1 expression. Then the function role
of miRNA in colorectal cancer liver metastasis was fur-
ther investigated by experiment design.
Materials and methods
Animals
Four-week-old male athymic BALB/c nu/nu nude mice
(weighing from 15 to 18 g) were obtained from ShanghaiSLAC Laboratory Animal Co. Ltd. (China). The bedding
materials, drinking water, feed pellets and other items in
contact with the animals were all autoclaved. The experi-
ment and feedings were in SPF (specific-pathogen-free)
condition according to the SYXK 2007–0001 standard.
The animals were cultured in the animal lab in Shanghai
Medical College of Fudan University in accordance with
Guide for the Care and Use of Laboratory Animals.
This study was approved by Ethics Committee of the
Renji Hospital, Shanghai Jiaotong University School of
Medicine, Shanghai, China.
Cell culture and infection
Human colorectal cancer cell lines SW1116 and HCT116
were provided by Shanghai Institute of Digestive Disease.
Cells were grown in complete medium supplemented with
10% fetal bovine serum (Gibco, CA, USA) and cultured in
a 37°C humidified atmosphere of 5% CO2. One milliliter
volume of pCDH cDNA lentivectors/green fluorescent
protein (GFP) (5 × 108 TU/mL, Shanghai Ming Hong
Biotech Co. Ltd., China) was added to 1 ml single cell
suspension (1 × 107/mL cells) of SW1116 and HCT116
to infect cells (multiplicity of infection was 50). The
lentivirus infection efficiency was observed using fluor-
escence microscope 3 days after infection. Cells were
collected 5 days after infection for subsequent animal
model development.
Liver-metastatic model construction
Prior to trial, 40 nude mice were fasted for 12 h and then
weighted. The mice were anesthetized with an intraperito-
neal injection of 1% pentobarbital sodium (45 mg/kg) and
placed in a supine position on the operating table. The
skin was disinfected with 75% alcohol and oblique incision
was made on left back (below conjunction of left posterior
axillary line and costal margin) for 0.5 to 1.0 cm to expose
spleen. Then the spleen was pulled out of the abdominal
cavity gently and 5 × 106/mL colorectal cancer cells in
single suspension were injected slowly into spleen using
five-gauge needle. Each nude mouse was injected for
0.2 ml over 3 min with visible splenic capsule swelling
and whitening. After injection and needle withdrawal,
75% ethanol cotton swab was used for hemostasis op-
pression for 2 min, by which extravasated cancer cells
were also killed to prevent intra-abdominal metastasis.
The spleen was removed at 10 min after injection and
then 3–0 absorbable sutures were used for abdomen
closure. The mice were fed normal diet after waking up
from anesthesia. The whole operation process followed
the principles of aseptic surgery. Thirty-five days later
after injection, the mice were sacrificed. The distribution
of colorectal cancer cells in various organs were observed
with fluorescence dissecting microscope (Qwin, Leica).
The percentage of fluorescent area to the liver surface area
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incidence.
Bioinformatics analysis of miRNAs that regulate the
MACC-1 expression
We extracted the whole genome sequence of MACC-1
from the National Center for Biotechnology Informa-
tion (NCBI, Gene ID: 346389), especially the 3′-UTR
(untranslated regions) sequence. The miRNAs profile
that might regulate MACC-1 expression was predicted
using miRbase (http://www.mirbase.org/index.shtml) and
microRNA.org (http://www.microrna.org/microrna/home.
do). Expect (E) value was used to choose the probable
regulation miRNA. The smaller the E value is, the more
probable the miRNA regulation of MACC-1 is.
RNA extraction and quantitative RT-PCR (qRT-PCR)
analysis
Total RNA was extracted from colorectal cancer cell lines
(SW1116 and HCT116) with TRIzol reagent (Invitrogen,
CA, USA). Housekeeping gene of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as in-
ternal control. MACC-1 mRNA level was measured
with Access RT-PCR kit (Promega, USA). Hairpin-it
miRNAs qPCR kit (GenePharma, China) was used to
detect the hsa-miR-574-5p expression in SW1116 and
HCT116 cell lines with stem-loop reverse transcription.
The primers used in the study were shown as follows:
MACC-1 (3′UTR sequence) primers, forward 5′-TTG
CGGAGGTCACCATAGC-3′; reverse 5′-TTTCCAACAA




The amplified PCR products of 3′UTR sequence of
wild type MACC-1 or mutant MACC-1 containing the
putative has-miR-574-5p binding site were transformed
into 293 T cells by pGL3 vector. The procedures were per-
formed according to manufacture’s instruction of lipofec-
tamine 2000 (Invitrogen, USA). At 24 h after transfection,
luciferase activity was detected by Dual-Glo™ Luciferase
Assay System (E2920, promega) and normalized by Renilla
activity.
Transfection of hsa-miR-574-5p antisense or miRNA mimic
into SW1116 and HCT116 cell lines
Lipofectamine 2000 was used for oligonucleotide trans-
fection. Three transfection groups were used for each
cell line: control group which was transfected with
5 mg/L liposome only; mimic oligonucleotide group
(mimic group) which was transfected with mixture of
100 nM mimic oligonucleotide and liposome; antisense
oligonucleotide group (inhibitor group) which wastransfected with mixture of 100 nM antisense oligo-
nucleotide and liposome. The transfection was con-
ducted in triplicate for each group. Cells were observed
by inverted microscopy 24, 48, 72, and 96 h after trans-
fection. Oligonucleotides expression was confirmed by
RT-PCR.Western-blot to detect MACC-1 protein expression in
hsa-miR-574-5p antisense or miRNA mimic transfected
SW1116 and HCT116 cell lines
The cells were lysed with 2× lysis buffer on ice for
15 min and broken by ultrasonic disrupter at 4°C. After
centrifugation at 12,000 g for 15 min, protein concentra-
tion in supernatant was measured. Protein (40 μg) was
loaded onto a 10% SDS-PAGE gel (30 mA for 2 h) and
transferred onto PVDF membrane (400 mA for 2 h, at
4°C). After probed with 1:1000 diluted rabbit polyclonal
MACC-1 antibody (Abcam, MA, USA) at 4°C over-
night, the blots were subsequently incubated with HRP
(horseradish peroxidase) - conjugated secondary antibody
(1:5000). The same results were repeated for seven times.Cell colony formation, invasion and spheroid formation
after transfection
Log phase cells were digested by trypsin and re-suspended
in complete medium to prepare cell suspension. Hemacy-
tometer was used to determine cell count. Cells were
seeded at a density of 500 cells per well into 96-well plates
in triplicate for each group, and incubated for another
3 days. Medium was changed every 3 days. Cellomics
Array Scan was used to scan and image each well to
analyze number and size of clones as well as the number
of cells in each clone.
For invasion assay, 1.0 × 105 cells in 1% FBS (fetal bovine
serum) were added to upper chamber pre-coated with
80 μL diluted matrigel matrix (BD, NJ, USA). Then 600 μl
complete medium was added to the matched lower
chamber. After 24–72 h incubation, noninvaded cells
were removed from the upper surface of the transwell
membrane with a cotton swab. Invaded cells on the lower
membrane surface were fixed in paraformaldehyde for
15 min, and stained with 500 μL Giemsa solution. Five
randomly selected fields were photographed with Image-
Pro Plus software, and then counted.
Cell suspension (5 × 103 cells, 200 μl) was added into
each well of a 96-well plate. Relatively loose spheroids
were visible after 3 days. The medium was then refreshed
and cells were cultured for another 3 days to form bigger
spheroids. Inverted phase contrast microscope was used
to observe the size and morphology of cell spheroids. The
diameter of spheroid was measured at day 7 and the size
was compared among experimental groups [23].
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All data were expressed as mean ± standard deviation
(SD) and processed using SPSS12.0 statistical software.
A P-value less than 0.05 was considered to be statisti-
cally significant.Results
Bioinformatics analysis of miRNAs regulating MACC-1
expression
The miRNAs that might regulate the MACC-1 gene
expression was identified by bioinformatics analysis. The
top 15 were shown in Table 1. Among those miRNAs,
hsa-miR-574-5p expression level may be correlated to
MACC-1 expression for the E value (0.10) was relatively
lower.Incidences of liver metastasis induced by HCT116 or
SW1116 tumor cells
Two human colorectal cancer cell lines SW1116 and
HCT116 labeled with GFP were injected through spleen
into male athymic BALB/c nu/nu nude mice to develop
liver-metastatic models, respectively and liver-metastatic
mice model was successfully constructed. Five weeks after
spleen injection, GFP expression was visible in livers from
7 out of 20 nude mice in SW1116 group (7/20). While it
was visible in livers only from 6 out of 20 nude mice in
HCT116 group (6/20). The mean ratio of tumor volume
induced by SW1116 cells (25.0 ± 4.4%) was significantly
higher than that induced by HCT116 cells (16.0 ± 2.5%,
P < 0.01, Figure 1A, B, C).Table 1 The miRNAs profile that might regulate the MACC-1
Accession ID Query start Query end Subject s
MIMAT0015090 hsa-miR-1273d 21 45 1
MIMAT0004795 hsa-miR-574-5p 81 103 1
MIMAT0018079 hsa-miR-1273e 30 47 5
MIMAT0005926 hsa-miR-1273 863 886 1
MIMAT0005876 hsa-miR-1285 870 889 1
MIMAT0003284 hsa-miR-616* 89 108 3
MIMAT0002820 hsa-miR-497 371 390 2
MIMAT0015090 hsa-miR-1273d 243 267 1
MIMAT0004952 hsa-miR-665 216 229 3
MIMAT0005583 hsa-miR-1228 189 205 4
MIMAT0005577 hsa-miR-1226 88 104 6
MIMAT0004805 hsa-miR-616 91 105 2
MIMAT0003239 hsa-miR-574-3p 49 70 1
MIMAT0005944 hsa-miR-1252 112 133 1
MIMAT0009979 hsa-miR-2054 250 271 2MACC-1 and hsa-miR-574-5p mRNA levels in SW1116 and
HCT116 cell lines
We performed qRT-PCR analysis to detect the mRNA
level of MACC-1 and hsa-miR-574-5p in SW1116 and
HCT116 cell lines. MACC-1 mRNA level in HCT116
cells with lower metastasis potential was significantly
lower than that in SW1116 cells, which has higher me-
tastasis potential (P < 0.01, Figure 2A, B). The mRNA
level of hsa-miR-574-5p in HCT116 cells was higher
than that in SW1116 cells (P < 0.01, Figure 2C). Our re-
sults indicated that an inverse correlation between hsa-
miR-574-5p and MACC-1 at mRNA level was observed
in the SW1116 and HCT116 cell lines.
Has-miR-574-5p directly targets MACC-1
We co-transfected MACC-1 (3′UTR sequence) vector
and hsa-miR-574-5p or negative control into cells. The
luciferase activity of wt-MACC1 group was significantly
reduced comparing with wt-MACC1-NC group (P < 0.05,
Figure 2D). There were no significant differences between
mu-MACC1-NC group and mu-MACC1 group (P > 0.05,
Figure 2D), demonstrating that miRNA could not com-
bine to the mutant 3′UTR. The results showed that has-
miR-574-5p might inhibit MACC1 expression.
The effect of hsa-miR-574-5p antisense and miRNA
mimics transfection on MACC-1 protein expression in
SW1116 and HCT116 cell lines
Compared to corresponding control group, the protein ex-
pression of MACC-1 was down-regulated in mimic
groups in both SW1116 and HCT116 cell lines (P < 0.05),
as shown in Figure 3A, B. Compared to correspondinggene expression (Top 15)
tart Subject end strand score E (expect) value Alignment
25 - 98 0.015 Align
23 + 88 0.10 Align
22 - 81 0.39 Align
24 - 75 1.1 Align
20 - 73 1.7 Align
22 - 73 1.8 Align
21 - 73 1.8 Align
25 + 71 2.5 Align
16 + 70 3.0 Align
20 + 67 5.7 Align
22 + 67 3.2 Align
16 + 66 6.9 Align
22 - 65 8.4 Align
22 - 65 8.4 Align
23 - 65 8.4 Align
Figure 1 Comparison of liver metastasis incidence in SW1116 and HCT116 injected nude mice. A. liver metastasis in HCT116 cells injected
nude mice; B. liver metastasis in SW1116 cells injected nude mice; C. SW1116 cells shows higher incidence of liver metastasis than HCT116 cells
(✩P < 0.01 vs. SW1116).
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up-regulated in inhibitor group in both SW1116 and
HCT116 cell lines (P < 0.05), also shown in Figure 3A, B.
The protein expression of has-miR-574-5p was reduced in
antisense transfected HCT116 cells, while it was increased
in miRNA mimics transfected SW1116 cells (Figure 3C).
Thus, it was indicated that hsa-miR-574-5p negatively reg-
ulated MACC-1 expression at protein level.Figure 2 The mRNA expression levels of MACC-1 and hsa-miR-574-5p
HCT116 cells is significant lower than that in SW1116 cells (✩P < 0.01 vs. HC
than that in SW1116 cell (✩P < 0.01 vs. SW1116). D. Relative luciferase activi
mutant MACC-1. NC: negative control.The effect of hsa-miR-574-5p on colony formation, cell
invasion and cell spheroid formation in SW1116 and
HCT116 cell lines
To study the effect of has-miR-574-5p on colony for-
mation, cell invasion and cell spheroid formation, the
antisense transfected HCT116 cells and miRNA mimics
transfected SW1116 cells were investigated. It showed that
the decreased expression of has-miR-574-5p in HCT116in SW1116 and HCT116 cell lines. A&B. MACC-1 mRNA level in
T116); C. hsa-miR-574-5p mRNA level in HCT116 is significant higher
ty after transfecting has-miR −574-5p into wild type MACC-1 and
Figure 3 The effect of hsa-miR-574-5p antisense and miRNA mimics transfection on MACC-1 expression in SW1116 and HCT116 cell
lines. A&B. Effect of hsa-miR-574-5p on MACC-1 expression in HCT116 and SW1116 cells; compared with control group, mimic group reduced
MACC-1 expression, while inhibitor group increased MACC-1 expression (*P < 0.05, inhibitor vs. control group; #P < 0.05, mimic vs. control group;
★P < 0.01, mimic vs. control group); C. hsa-miR-574-5p expression was reduced in antisense (inhibitor group) transfected HCT116 cells, while it
was increased in miRNA mimics (mimic group) transfected SW1116 cells (#P < 0.01 vs. control group).
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ducing increased colony formation, cell invasion and cell
spheroid formation of HCT116 cells, compared to control
group (P < 0.05), as shown in Figure 4. Conversely, the
increased expression of has-miR-574-5p in SW1116
cells decreased colony formation, cell invasion and cell
spheroid formation, compared to control group (P < 0.05),
as shown in Figure 4.
Discussion
Lots of reports have shown that miRNAs are important
regulators for functional genes involved in oncogenesis
and development. The miRNAs abnormalities are found
in various key processes of tumor metastasis, in which
miRNAs can regulate a variety of genes and are pivotal
for invasion or metastasis [14,24-29]. In the present
work, we identified the miRNAs profile that might regu-
late the MACC-1 gene expression by bioinformatics ana-
lysis. The hsa-miR-574-5p was chosen for further analysis.
Subsequently, results demonstrated that hsa-miR-574-5p
was involved in the regulation of MACC-1, playing a func-
tional role in colorectal cancer liver metastasis.
We successfully constructed liver-metastatic nude mice
model by injecting two human colorectal cancer cell lines
labeled with GFP through spleen. SW1116 cells repre-
sented a higher metastasis potential in the model than thatof HCT116 cells, so we selected these two cell lines for
further function analysis. The E value of hsa-miR-574-
5p is relatively lower. Inhibition of hsa-miR-574-5p sup-
pressed the growth of colorectal tumors in the nude
mice [22]. So the hsa-miR-574-5p is chosen for investi-
gating if this miRNA is correlated with the expression
of MACC-1.
In this study, qRT-PCR analysis indicated that an in-
verse correlation between hsa-miR-574-5p and MACC-1
at mRNA level was observed in the SW1116 and
HCT116 cell lines. Luciferase experiments showed that
miRNA could bind to the 3′UTR but not the mutant 3′
UTR. Furthermore, the effect of hsa-miR-574-5p anti-
sense and miRNA mimics transfection on MACC-1 ex-
pression in SW1116 and HCT116 cell lines showed that
hsa-miR-574-5p negatively regulated MACC-1 expres-
sion at protein level. Therefore, it was verified that hsa-
miR-574-5p was negatively involved in the regulation of
MACC-1 at mRNA and protein levels. Subsequently, we
investigated the functional role of hsa-miR-574-5p in
the colorectal cancer liver metastasis. Though HCT116
cells represented a low metastasis potential, siRNA me-
diated knockdown of has-miR-574-5p increased colony
formation, cell invasion and cell spheroid formation in
HCT116 cells, compared to control group. The reverse
result was obtained in the miRNA mimics transfected
Figure 4 The effect of hsa-miR-574-5p antisense and miRNA mimics transfection on cell colony formation, cell invasion and cell
spheroid formation in SW1116 and HCT116 cell lines. A&B. The effect of hsa-miR-574-5p antisense and miRNA mimics transfection on cell colony
formation in SW1116 and HCT116 cell lines (*P < 0.01 vs. control group). C&D. The effect of hsa-miR-574-5p antisense and miRNA mimics transfection
on cell invasion in SW1116 and HCT116 cell lines (#P < 0.01 vs. control group); E&F. The effect of hsa-miR-574-5p antisense and miRNA mimics
transfection on cell spheroid formation in SW1116 and HCT116 cell lines (*P < 0.01 vs. control group, #P < 0.05 vs. control group).
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affected colony formation, cell invasion and cell spher-
oid formation by mediating the expression of MACC-1.
Increased MACC-1 expression in colorectal cancer
cells can induce proliferation, migration and invasion of
cancer cells in vitro, while promoting liver metastasis in
a xenograft model [30]. Previous research also showed
that MACC-1 protein in colorectal cancer could bind to c-
met promoter through nuclear translocation to up-regulate
c-met gene transcription and expression [9,31-33]. The
activation of HGF/c-Met signaling pathway not only
can promote the spread of colorectal cancer cells [9],
but also can promote colorectal cancer liver metastasis
[34]. In contrast, the inhibition of this pathway can re-
duce tumor invasion and metastasis [35]. Therefore, we
speculated that hsa-miR-574-5p played a suppressive
role in colorectal cancer liver metastasis by negatively
involved in the down-regulation of MACC-1 expression.
It was verified that hsa-miR-574-5p was negatively
involved in the regulation of MACC-1 at mRNA and
protein levels. Moreover, hsa-miR-574-5p affected the
colony formation, cell invasion and cell spheroid for-
mation. Taken together, our findings partly elucidated
that hsa-miR-574-5p played a suppressive role in colo-
rectal cancer liver metastasis by negatively directing
the expression of MACC-1. The results in this study
might offer a novel therapy option of hsa-miR-574-5p
in colorectal cancer liver metastasis. However, there
are some limitations in this study. First, we just only
investigated the hsa-miR-574-5p function of invasion
in vitro. It is needed to demonstrate the role by in vivo
experiments. Second, although the hsa-miR-574-5p may
be the potential therapy for colorectal cancer liver metas-
tasis therapy, the function of it in patients with colorectal
cancer liver metastasis need further experiments to
explore.
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